Initiate and Maintain Physical Activity in Clinics: The IMPACT Diabetes Study
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 4/6/2019 |
| Start Date: | October 2016 |
| End Date: | December 2019 |
The Initiate and Maintain Physical Activity in Clinics (IMPACT) study will determine the
optimal and feasible level of frequency of structured contact needed in a clinical setting
for adult patients with Type 2 Diabetes Mellitus to initiate and maintain physical activity
recommendations long-term.
optimal and feasible level of frequency of structured contact needed in a clinical setting
for adult patients with Type 2 Diabetes Mellitus to initiate and maintain physical activity
recommendations long-term.
The IMPACT Study will compare the health outcomes and lifestyle habits amongst the three
groups of study participants. Study participants will be randomized into three exercise
group. Group 1 will participate in instructor-led exercise training sessions 1 time per week,
for 24 weeks (approximately 6 months). Group 2 will participate in instructor-led exercise
training sessions 3 times per week, for 24 weeks (approximately 6 months). Group 3 will not
attend any instructor-led exercise training sessions. All groups will be encouraged to see
their usual providers for routine healthcare, and continue their usual medication regimen.
groups of study participants. Study participants will be randomized into three exercise
group. Group 1 will participate in instructor-led exercise training sessions 1 time per week,
for 24 weeks (approximately 6 months). Group 2 will participate in instructor-led exercise
training sessions 3 times per week, for 24 weeks (approximately 6 months). Group 3 will not
attend any instructor-led exercise training sessions. All groups will be encouraged to see
their usual providers for routine healthcare, and continue their usual medication regimen.
Inclusion Criteria:
- Recent hemoglobin A1c result between 6.5 and 13.0%
- Diagnosed with Type 2 Diabetes Mellitus
- Able and willing to enroll and meet the requirements of the study
Exclusion Criteria:
- Inability to speak, read or understand English
- Long-term current use or dependency on insulin
- Systolic blood pressure >180 mm Hg or diastolic blood pressure >100 mm Hg
- Resting heart rate > 120 bpm
- History of or present heart or cardiovascular conditions
- History of or present respiratory disease
- History of or present spinal cord injury
- History of stroke or Transient Ischemic Attack (TIA)
- History of cancer diagnosis in the past 5 years or present cancer diagnosis
- Medical, psychiatric, behavioral limitations that may interfere with study
participation
- Participating in other clinical trials that may interfere with study procedures and
outcomes
- Currently pregnant or plans to become pregnant within three years
We found this trial at
1
site
Palo Alto, California 94304
Principal Investigator: Latha P Palaniappan, MD, MS
Phone: 650-721-6403
Click here to add this to my saved trials
